Journal of Dermatological Treatment

Article	Citations
Minoxidil: a comprehensive review	75
Real-world practice indirect comparison between guselkumab, risankizumab, and tildrakizumab: results from an Italian 28-week retrospective study	58
Melasma treatment: a systematic review	44
Guselkumab is efficacious and safe in psoriasis patients who failed anti-IL17: a 52-week real-life study	43
Dupilumab in prurigo nodularis: a systematic review of current evidence and analysis of predictive factors to response	39
Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study	34
Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia	32
Dupilumab for the treatment of adult atopic dermatitis in special populations	30
JAK inhibitors in lichen planus: a review of pathogenesis and treatments	26
A comprehensive review of platelet-rich plasma for the treatment of dermatologic disorders	25
Beneficial effect of Lactobacillus plantarum IS-10506 supplementation in adults with atopic dermatitis: a randomized controlled trial	25
Topical corticosteroid withdrawal (‘steroid addiction’): an update of a systematic review	25
Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase	24
Biologic treatment for psoriasis in cancer patients: should they still be considered forbidden?	24
Finasteride for hair loss: a review	24
Cosmetic skin lightening use and side effects	23
Antifungal resistance in superficial mycoses	23
Soluble biomarkers for diagnosis, monitoring, and therapeutic response assessment in psoriasis	22
Quantifying patient preferences for systemic atopic dermatitis treatments using a discrete-choice experiment	22
Biologic therapies for plaque type psoriasis in patients with previous malignant cancer: long-term safety in a single- center real-life population	20
Safety of baricitinib for the treatment of atopic dermatitis over a median of 1.6 years and up to 3.9 years of treatment: an updated integrated analysis of eight clinical trials	20
Risk of COVID-19 infection, hospitalization, and mortality in patients with psoriasis treated by interleukin-17 inhibitors	20
Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis	19
Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy: baseline characteristics of participants on the EUROSTAD prospective observational study	19
Guselkumab, tildrakizumab, and risankizumab in a real-world setting: drug survival and effectiveness in the treatment of psoriasis and psoriatic arthritis	18

Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE study	18
Elevation of peripheral blood eosinophils during dupilumab treatment for atopic dermatitis is associated with baseline comorbidities and development of facial redness dermatitis and ocular surface dis	17
Upadacitinib for the treatment of concomitant psoriasis and atopic dermatitis: a case series	16
Generalized pustular psoriasis: the new era of treatment with IL-36 receptor inhibitors	16
Efficacy, safety, and drug survival of patients with psoriasis treated with IL-17 inhibitors – brodalumab, ixekizumab, and secukinumab: real-world data from the Czech Republic BIOREP registry	16
The prevention effect of probiotics against eczema in children: an update systematic review and meta-analysis	16
Efficacy of GLP-1rA, liraglutide, in plaque psoriasis treatment with type 2 diabetes: a systematic review and meta-analysis of prospective cohort and before-after studies	15
The impact of COVID-19 pandemic on psoriasis patients, and their immunosuppressive treatment: a cross-sectional multicenter study from Turkey	15
PASI 100 response rates in moderate to severe psoriasis: a systematic literature review and analysis of clinical practice guidelines	15
Treatment adherence and persistence of seven commonly prescribed biologics for moderate to severe psoriasis and psoriatic arthritis in a U.S. commercially insured population	15
The dark side of the moon: the immune-mediated adverse events of IL-17A/IL-17R inhibition	15
Real-world switching patterns and associated characteristics in patients with psoriasis treated with biologics in the United States	14
Deucravacitinib in the treatment of psoriasis	14
Artificial intelligence image recognition of melanoma and basal cell carcinoma in racially diverse populations	14
Bullous pemphigoid induced by biologic drugs in psoriasis: a systematic review	13
Assessment of various intralesional injections in keloid: comparative analysis	13
Dietary habits and perceptions of psoriatic patients: Mediterranean versus Asian diets	13
Laboratory safety of dupilumab for up to 3 years in adults with moderate-to-severe atopic dermatitis: results from an open-label extension study	13
Lack of reactivation of tuberculosis in patients with psoriasis treated with secukinumab in a real-world setting of latent tuberculosis infection	12
Unmet needs in atopic dermatitis management: an expert consensus	12
Treatment of patients with chronic pruritus of unknown origin with dupilumab	12
Benefits, drawbacks, and challenges of social media use in dermatology: a systematic review	12
Baricitinib for the treatment of atopic dermatitis	12
New-onset and flares of psoriasis after COVID-19 infection or vaccination successfully treated with biologics: a case series	12
Real-world evidence for ixekizumab in the treatment of psoriasis and psoriatic arthritis: literature review 2016–2021	11
Effectiveness of risankizumab in plaque psoriasis with involvement of difficult-to-treat areas: a real-world experience from two referral centers	11
Ustekinumab as adjuvant treatment for all pyoderma gangrenosum subtypes	11
Patient and caregiver preferences on treatment attributes for atopic dermatitis	11
Tralokinumab rapidly improves subjective symptoms and quality of life in patients with moderate-to-severe atopic dermatitis: a real-life 16-week experience	11
Dupilumab for the treatment of atopic dermatitis: real-world data from the Czech Republic BIOREP registry	11
Successful treatment of paediatric generalized pustular psoriasis with secukinumab: a case series	11
Pregnancy outcomes in patients with psoriasis, psoriatic arthritis, or axial spondyloarthritis receiving ixekizumab	11
A review of IL-36: an emerging therapeutic target for inflammatory dermatoses	10
Emerging topical therapies to treat pigmentary disorders: an evidence-based approach	10
The prevalence of SARS-CoV-2 infection and the severity of the course of COVID-19 in patients with psoriasis treated with biologic therapy	10
Effects of TNF inhibitors and an IL12/23 inhibitor on changes in body weight and adipokine levels in psoriasis patients: a 48-week comparative study	10
Dupilumab for atopic dermatitis: a real-world Portuguese multicenter retrospective study	10
Real-life experience with chlormethine gel for early-stage mycosis fungoides with emphasis on types and management of cutaneous side-effects #	10
The differential effects of upadacitinib treatment on skin rashes of four anatomical sites in patients with atopic dermatitis	10
Dupilumab as promising treatment for prurigo nodularis: current evidences	10
A consistent skin care regimen leads to objective and subjective improvements in dry human skin: investigator-blinded randomized clinical trial	10
Improvement in sleep and itch and enhanced quality of life in adult patients with moderate-to-severe atopic dermatitis: results from a phase 3 trial of baricitinib therapy	10
A prospective, split-face study comparing 1,064-nm picosecond Nd:YAG laser toning with 1,064-nm Q-switched Nd:YAG laser toning in the treatment of melasma	10
Dermoscopic evaluation of tranexamic acid versus Vitamin C, with microneedling in the treatment of melasma: a comparative, split-face, single-blinded study	10
Long-term maintenance treatment of psoriasis: the role of calcipotriol/betamethasone dipropionate aerosol foam in clinical practice	9
Platelet-rich plasma for genital lichen sclerosus: analysis and results of 94 patients. Are there gender-related differences in symptoms and therapeutic response to PRP?	9
Cutaneous adverse events of immune checkpoint inhibitor therapy: incidence and types of reactive dermatoses	9
Fractional erbium:YAG laser (2940 nm) plus topical hydroquinone compared to intradermal tranexamic acid plus topical hydroquinone for the treatment of refractory melasma: a randomized controlled trial	9
Anti-IL-23 and anti-IL-17 drugs for the treatment of non-pustular palmoplantar psoriasis: a real-life retrospective study	9
Emerging treatments for bullous pemphigoid	9

Efficacy, tolerability, patient usability, and satisfaction with a 2 mL pre-filled syringe containing secukinumab 300 mg in patients with moderate to severe plaque psoriasis: results from the phase 3	9
Eczema control and treatment satisfaction in atopic dermatitis patients treated with dupilumab – a cross-sectional study from the BioDay registry	9
Efficacy and predictive factors of cyclosporine A in alopecia areata: a systematic review with meta-analysis	9
Systematic literature review of long-term efficacy data for topical psoriasis treatments	9
Itraconazole versus propranolol: therapeutic and pharmacologic effect on serum angiopoietin-2 in patients with infantile hemangioma	8
Pediatric hidradenitis suppurativa: epidemiology, disease presentation, and treatments	8
Isotretinoin for acne vulgaris – an update on adverse effects and laboratory monitoring	8
Biologics recommendations for patients with psoriasis: a critical appraisal of clinical practice guidelines for psoriasis	8
Scalp hair regrowth is associated with improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata: results from two randomized controlled trials	8
Drug survival of secukinumab, ustekinumab, and certolizumab pegol in psoriasis: a 2-year, monocentric, retrospective study	8
The efficacy and safety of JAK inhibitors for atopic dermatitis: a systematic review and meta-analysis	8
Network meta-analyses comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis at 24–28 and 48–52 weeks	8
Liposomal azelaic acid 20% cream vs hydroquinone 4% cream as adjuvant to oral tranexamic acid in melasma: a comparative study	8
Efficacy of autologous platelet-rich plasma therapy versus topical Minoxidil in men with moderate androgenetic alopecia: a randomized open-label trial	8
Adipose-derived stem cell exosomes for treatment of dupilumab-related facial redness in patients with atopic dermatitis	8
Efficacy of adalimumab in pediatric generalized pustular psoriasis: case series and literature review	8
Racial and ethnic diversity of US participants in clinical trials for acne, atopic dermatitis, and psoriasis: a comprehensive review	8
Use of systemic therapies for psoriasis in the COVID-19 era	8
The efficacy of probiotics supplementation for the treatment of atopic dermatitis in adults: a systematic review and meta-analysis	8
Managing pediatric psoriasis: update on treatments and challenges—a review	8
Clinical and histologic features associated with lentigo maligna clearance after imiquimod treatment	7
Clinical implications and predictive values of early PASI responses to tildrakizumab in patients with moderate-to-severe plaque psoriasis	7
Efficacy and safety of dimethylfumarate in elderly psoriasis patients: a multicentric Italian study	7
Neonatal epidermolysis bullosa: lessons to learn about genetic counseling	7
Hyperhidrosis and the risk of being treated for skin infections	7
Pulsed dye laser versus intense pulsed light for facial erythema of rosacea: a systematic review and meta-analysis	7
Limb melanomas: acral melanomas have worse survival	7
A time series analysis of immune checkpoint inhibitor use in the United States Medicare population: 2014–2019	7
Real-world outcomes following switching from anti-TNF reference products to biosimilars for the treatment of psoriasis	7
Evaluating social media as a source of patient information regarding psoriasis treatments using the DISCERN instrument	7
Maintained improvement in physician- and patient-reported outcomes with baricitinib in adults with moderate-to-severe atopic dermatitis who were treated for up to 104 weeks in a randomized trial	7
Probiotics for the prevention of atopic dermatitis in infants from different geographic regions: a systematic review and Meta-analysis	7
A clinical perspective on risk factors and signs of subclinical and early psoriatic arthritis among patients with psoriasis	7
Combined chemical peels versus trichloroacetic acid (TCA) for treating melasma: a split face study	7
Exploring determinants of psoriasis patients’ treatment choices: a discrete-choice experiment study in the United States and Germany	7
Treatment preferences among patients with mild-to-moderate atopic dermatitis	7
Preliminary results on long-term follow-up of systemic sclerosis patients under extracorporeal photopheresis	7
Surgical treatment of verrucous carcinoma: a review	7
Efficacy, safety, usability, and acceptability of risankizumab 150 mg formulation administered by prefilled syringe or by an autoinjector for moderate to severe plaque psoriasis	7
Concurrent vitiligo and atopic dermatitis successfully treated with upadacitinib: a case report	7
Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) with probable mesentery involvement with associated hemophagocytic syndrome (HPS) – how to treat it?	7
Brodalumab efficacy in bio-naïve psoriasis patients: real-life experience of 202 subjects up to 48 weeks	7
Matching-adjusted indirect comparison of efficacy outcomes in trials of calcipotriol plus betamethasone dipropionate foam and cream formulations for the treatment of plaque psoriasis	7
The current treatment landscape in adult atopic dermatitis in the United States: results from a cross-sectional real-world study	6
A qualitative study of dermatology patients and providers to understand discordant perceptions of symptom burden and disease severity	6
Exploring the burden of xerosis cutis and the impact of dermatological skin care from patient's perspective	6
Efficacy and safety of abrocitinib for the treatment of moderate-to-severe atopic dermatitis: a meta-analysis of randomized clinical trials	6
Patient assessment of 5-fluorouracil and imiquimod for the treatment of actinic keratoses: a retrospective study of real-world effectiveness	6
A split face comparative study between intradermal tranexamic acid and Erbium-YAG laser in treatment of melasma	6
Paradoxical tralokinumab-induced psoriasis in a patient with atopic dermatitis	6
Topical rapamycin in the treatment of facial angiofibromas in tuberous sclerosis: a systematic review based on evidence	6
Pyoderma gangrenosum and Behçet’s-like disease induced by secukinumab: a paradoxical drug reaction	6
A hyaluronic acid-based micro-filler improves superficial wrinkles and skin quality: a randomized prospective controlled multicenter study	6
Exploring the potential of nanocarriers in antipsoriatic therapeutics	6
Human adipose tissue-derived MSCs improve psoriasis-like skin inflammation in mice by negatively regulating ROS	6
Treatment goals and preferences of pediatric psoriasis patients, young adults, and parents	6
Long-term efficacy and safety of secukinumab in real life: a 240 weeks multicenter study from Southern Italy	6
Effectiveness of ustekinumab in patients with atopic dermatitis: analysis of real-world evidence	6
Autologous platelet-rich plasma ‘fluid’ versus ‘gel’ form in combination with fractional CO2laser in the treatment of atrophic acne scars: a split-face randomized clinical trial	6
Methotrexate dosing regimen for plaque-type psoriasis: an update of a systematic review	6
Effects of TNF-α inhibition on pre-clinical enthesitis: observational study on 49 psoriatic patients	6
Topical prebiotics/postbiotics and PRURISCORE validation in atopic dermatitis. International study of 396 patients	5
Serum drug levels and anti-drug antibodies in the context of dose tapering by interval prolongation of adalimumab, etanercept and ustekinumab in psoriasis patients: results of the CONDOR trial	5
Efficacy and safety of abrocitinib monotherapy in adolescents and adults: a post hoc analysis of the phase 3 JAK1 atopic dermatitis efficacy and safety (JADE) REGIMEN clinical trial	5
Prevalence, risk and severity of SARS-CoV-2 infections in psoriasis patients receiving conventional systemic, biologic or topical treatment during the COVID-19 pandemic: a cross-sectional cohort study	5
Initial validation of a new device for facial skin analysis	5
An anchored matching-adjusted indirect comparison of fixed-dose combination calcipotriol and betamethasone dipropionate (Cal/BDP) cream versus Cal/BDP foam for the treatment of psoriasis	5
Systematic review of mesotherapy: a novel avenue for the treatment of hair loss	5
Trends and risk factors in the antibiotic management of skin and soft tissue infections in the United States	5
Anti-IL-17A blockade did not significantly reduce inflammatory lesions in a placebo-controlled pilot study in adult patients with moderate to severe acne	5
Evaluation of needling/microneedling as an adjunct to phototherapy in the treatment of stable acral vitiligo: a comparative clinical and immunohistochemical study	5
Use of autologous platelet-rich plasma in androgenetic alopecia in women: a systematic review and meta-analysis	5
Data mining for detecting signals of adverse drug reaction of doxycycline using the Korea adverse event reporting system database	5
Disease response and patient-reported outcomes among initiators of ixekizumab	5
RETRACTED ARTICLE: Secukinumab-induced paradoxical skin lesions, but successful treatment with tofacitinib in SAPHO syndrome: a case report	5
Burden of adult atopic dermatitis and unmet needs with existing therapies	5
Emerging systemic therapies for atopic dermatitis: biologics	5
Efficacy of tralokinumab after failure with upadacitinib and dupilumab in a patient affected by atopic dermatitis	5
Treatment of tardive dyskinesia: a review and update for dermatologists managing delusions of parasitosis	5
Dermoscopy-guided Mohs micrographic surgery in post-laser basal cell carcinomas: is dermoscopy helpful for demarcation of the surgical margin?	5

Evaluation of HLA class I and HLA class II allele profile and its relationship with clinical features in patients with alopecia areata: a case–control study	5
Treatment of generalized granuloma annulare with dupilumab	5
Patient preferences for atopic dermatitis treatments: a discrete choice experiment	5
Treatment satisfaction of patients with psoriasis with topical therapy in a real-world setting: unmet need for higher effectiveness	5
Photodynamic therapy combined with surgery versus Mohs micrographic surgery for the treatment of difficult-to-treat basal cell carcinoma: a retrospective clinical study	5
Safety of anti-IL-23 drugs in patients with moderate-to-severe plaque psoriasis and previous tuberculosis infection: a monocentric retrospective study	5
Upadacitinib for the treatment of atopic dermatitis in the elderly: an Italian case series of seven patients	5
Drug survival analysis of dupilumab and cyclosporin in patients with atopic dermatitis: a multicenter study	5
Effectiveness of switching from baricitinib 4 mg to upadacitinib 30 mg in patients with moderate-to-severe atopic dermatitis: a real-world clinical practice in Japan	5
Efficacy of biologics and oral small molecules for atopic dermatitis: a systematic review and meta-analysis	5
Real-world treatment patterns and healthcare costs in patients with psoriasis taking systemic oral or biologic therapies	5
Potential use of microwave technology in dermatology	5
Tofacitinib in the treatment of refractory eczemas – a case series	5
Clinical efficacy and safety of secukinumab for psoriasis in a real-world setting in Turkey	5
The impact of social media on dermatologists and in captivating their patients: a cross-sectional study	5
Intralesional corticosteroid injections are less painful without local anesthetic: a double-blind, randomized controlled trial	5
Treatment persistence of interleukin-17 inhibitor class drugs among patients with psoriasis in Japan: a retrospective database study	5
Successful treatment of alopecia universalis with abrocitinib: a case report	5
Deep learning-based fully automated diagnosis of melanocytic lesions by using whole slide images	5
Multipass low fluence, high-frequency 755-nm alexandrite laser versus high fluence, low-frequency 1064-nm long-pulsed Nd: YAG laser in axillary hair reduction of dark skin phototypes: an intra-individ	4
Zinc in dermatology	4
Efficacy and safety of JAK inhibitors in the treatment of alopecia areata in children: a systematic review and meta-analysis	4
Early clinical response to 5-fluorouracil 0.5% and salicylic acid 10% topical solution in the treatment of actinic keratoses of the head: an observational study	4
Evaluating patient experience and satisfaction with teledermatology for isotretinoin management: a structured qualitative interview study	4
Long-term safety and efficacy of anti-tumor necrosis factor-alpha biosimilar agents in the treatment of psoriasis: a single center study	4
Cannabinoids in hyperhidrosis	4
A case series evaluating microwave-based therapy for axillary hyperhidrosis and bromhidrosis	4
Intralesional corticosteroid administration in the treatment of keloids: a survey among Dutch dermatologists and plastic surgeons	4
Preliminary efficacy and safety analysis: 12-month results in 83 patients using a novel approach of widefield radiation therapy for extensive skin field cancerization with or without keratinocyte canc	4
Survival of guselkumab therapy in moderate to severe plaque psoriasis at 52 weeks in a real-world clinical setting: observational, retrospective, multi-centre study by the Spanish Psoriasis Group	4
Psychosocial impact of hidradenitis suppurativa: a practical guide for clinicians	4
The risk of hepatic adverse events of systemic medications for psoriasis: a prospective cohort study using the BIOBADADERM registry	4
Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience	4
RETRACTED ARTICLE: Evidence-based clinical practice guidelines for the management of psoriasis: systematic review, critical appraisal, and quality assessment with the AGREE II instrument	4
Two-year follow-up of a dose reduction strategy trial of biologics adalimumab, etanercept, and ustekinumab in psoriasis patients in daily practice	4
Analysis of predictive factors influencing dupilumab continuation rate in adult patients with atopic dermatitis: results from an Italian multicenter study	4
Should atopic dermatitis patients starting JAK inhibitors take prophylactic acyclovir?	4
Topical treatment for postinflammatory hyperpigmentation: a systematic review	4
Clinically meaningful improvements in cutaneous lesions and quality of life measures in patients with atopic dermatitis with greater pruritus reductions after treatment with 60 mg nemolizumab subcutan	4
Development of immunity-related adverse events correlates with baseline clinical factors, survival and response to anti-PD-1 treatment in patients with inoperable or metastatic melanoma	4
Exploring patient journeys through acne healthcare: a patient perspective	4
Internet-based survey intervention improves adherence to methotrexate among psoriasis patients	4
Five-year safety of tildrakizumab in patients with moderate-to-severe psoriasis from two phase 3 trials (reSURFACE 1 and reSURFACE 2): number needed to harm for occurrence of adverse events of special	4
Matching-adjusted indirect comparison (MAIC) results confirmed by head-to-head trials: a case study in psoriasis	4
Low irritation potential of tazarotene 0.045% lotion: Head-to-head comparison to adapalene 0.3% gel and trifarotene 0.005% cream in two studies	4
Real-world clinical outcomes of treatment with brodalumab in patients with moderate-to-severe psoriasis: a retrospective, 24-month experience from four academic dermatology centers in Greece	4
Use of systemic therapies in adults with atopic dermatitis: 12-month results from the European prospective observational study in patients eligible for systemic therapy for atopic dermatitis (EUROSTAD	4
Alleviation of isolated nail lichen planus by the JAK1/2 inhibitor Baricitinib: a case report	4
Endocrine mucin-producing sweat gland carcinoma: a systematic review and meta-analysis	4
Time to meaningful clinical response in reduction of itch in atopic dermatitis	4
A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years	4
A randomized split-face clinical trial of conventional vs indoor-daylight photodynamic therapy for the treatment of multiple actinic keratosis of the face and scalp and photoaging	4
Impact of PASI response on work productivity and the effect of risankizumab on indirect costs using machine learning in patients with moderate-to-severe psoriasis	3
Efficacy and safety of oral methotrexate versus oral mini pulse betamethasone therapy in the treatment of lichen planus: a comparative study	3
Methylprednisolone and local anesthetic for long-term postherpetic neuralgia: a meta-analysis	3
Clinical use of zinc in viral warts: a systematic review of the clinical trials	3
Communicating with patients through pictograms and pictures – a scoping review	3
Periocular molluscum contagiosum in an atopic dermatitis patient treated with upadacitinib	3
Efficacity of dupilumab in severe idiopathic cold urticaria: a case report	3
Exacerbation of psoriasis induced by lenalidomide in a patient with multiple myeloma	3
Potential biomarkers for psoriasis topical treatment by in-depth serum proteomics	3
Drug tolerability versus drug safety	3
Efficacy and safety of stromal vascular fraction on scar revision surgery: a prospective study	3
The cutaneous effects of androgens and androgen-mediated sebum production and their pathophysiologic and therapeutic importance in acne vulgaris	3
Effectiveness and safety of ustekinumab for the treatment of psoriasis; six years of clinical experience	3
Quality of life and patient-reported symptoms in a Phase 4, real-world study of tildrakizumab in patients with moderate-to-severe psoriasis: Week 28 interim analysis	3
Efficacy and safety evaluations of adalimumab biosimilars in the treatment of psoriasis	3
Efficacy of non-surgical monotherapies for hidradenitis suppurativa: a systematic review and network meta-analyses of randomized trials	3
Impact of secukinumab on patient-reported outcomes in biologic-naive patients with psoriasis in a US real-world setting	3
Effects and safety of fire needle adjuvant chemical peels therapy in acne vulgaris: a systematic review and meta-analysis	3
Dermal sensitization, safety, tolerability, and patient preference of tazarotene 0.045% lotion from five clinical trials	3
Impact of clinical and demographic characteristics on patient preferences for psoriasis treatment features: Results from a discrete-choice experiment in a multicountry study	3
Early itch relief with upadacitinib predicts later skin clearance in Atopic dermatitis	3
A case of junctional epidermolysis bullosa intermediate with collagen XVII deficiency treated with dupilumab	3
Development of a new classification and scoring system for scalp conditions: Scalp Photographic Index (SPI)	3
Patient preferences for topical psoriasis treatments: a discrete choice experiment	3
The efficacy and safety of topical 10% potassium hydroxide for molluscum contagiosum: a systematic review and meta-analysis	3
Future prospects in 3-dimensional (3D) technology and Mohs micrographic surgery	3
Axonal sensorimotor polyneuropathy after starting guselkumab	3
Ocular side effects of systemic isotretinoin – a systematic review and summary of case reports	3
Predictive factors for responders to upadacitinib treatment in patients with atopic dermatitis	3
Letter to the editor submitted in response to ‘Should the presence of psoriatic arthritis change how we manage psoriasis?’	3
Estimating the susceptibility to SARS-CoV-2 infection with rituximab use for pemphigus vulgaris	3
Uses of eye drops in dermatology, literature review	3
An updated systematic review and meta-analysis of efficacy and safety of Chinese herbal medicine for treating atopic dermatitis	3
The atopic dermatitis spectrum disorder. Recognizing the clinical heterogeneity in patients with atopic related skin conditions in order to improve therapeutic decision-making and outcomes: an expert	3
Cost per responder of adalimumab biosimilars versus methotrexate in patients with psoriasis: a real-life experience	3
Experiences and coping behaviors of patients with psoriasis: a qualitative study	3
Long-term effectiveness and safety of upadacitinib for Japanese patients with moderate-to-severe atopic dermatitis: a real-world clinical study	3
Complete response of extensive alopecia areata refractory to baricitinib after five months of treatment with upadacitinib	3
The economic burden and quality of life of patients with psoriasis treated with biologics in China	3
Dupilumab for the treatment of atopic dermatitis of the elderly: a real-life 52-week experience	3
Decoding infraorbital dark circles with lasers and fillers	3
Care and treatment needs of immunosuppressive therapy patients with warts and impact on everyday life: a qualitative study	3
Introducing a simplified titration scheme for dimethylfumarate (DMF) in patients with moderate-to-severe psoriasis: a case series	3